SK284204B6 - Použitie inhibítora H+, K+-ATPázy - Google Patents

Použitie inhibítora H+, K+-ATPázy Download PDF

Info

Publication number
SK284204B6
SK284204B6 SK1655-98A SK165598A SK284204B6 SK 284204 B6 SK284204 B6 SK 284204B6 SK 165598 A SK165598 A SK 165598A SK 284204 B6 SK284204 B6 SK 284204B6
Authority
SK
Slovakia
Prior art keywords
atpase inhibitor
hydrogen
omeprazole
alkyl
plasma profile
Prior art date
Application number
SK1655-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK165598A3 (en
Inventor
Christer Cederberg
George Sachs
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of SK165598A3 publication Critical patent/SK165598A3/sk
Publication of SK284204B6 publication Critical patent/SK284204B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
SK1655-98A 1996-06-20 1997-06-18 Použitie inhibítora H+, K+-ATPázy SK284204B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602442A SE9602442D0 (sv) 1996-06-20 1996-06-20 Administration of pharmaceuticals
PCT/SE1997/001098 WO1997048380A1 (en) 1996-06-20 1997-06-18 ADMINISTRATION REGIMEN OF H+, K+-ATPase INHIBITORS

Publications (2)

Publication Number Publication Date
SK165598A3 SK165598A3 (en) 1999-08-06
SK284204B6 true SK284204B6 (sk) 2004-10-05

Family

ID=20403092

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1655-98A SK284204B6 (sk) 1996-06-20 1997-06-18 Použitie inhibítora H+, K+-ATPázy

Country Status (28)

Country Link
US (4) US20010008900A1 (xx)
EP (1) EP0921787B1 (xx)
JP (1) JP2000512993A (xx)
CN (1) CN1178648C (xx)
AT (1) ATE252885T1 (xx)
AU (1) AU726859B2 (xx)
BR (1) BR9709838A (xx)
CA (1) CA2257405A1 (xx)
CZ (1) CZ298213B6 (xx)
DE (1) DE69725860T2 (xx)
DK (1) DK0921787T3 (xx)
EE (1) EE04606B1 (xx)
ES (1) ES2208921T3 (xx)
HK (1) HK1018590A1 (xx)
HU (1) HUP9901794A3 (xx)
IL (2) IL127542A0 (xx)
IS (1) IS2216B (xx)
NO (1) NO323295B1 (xx)
NZ (1) NZ332990A (xx)
PL (1) PL189716B1 (xx)
PT (1) PT921787E (xx)
RS (1) RS49590B (xx)
RU (1) RU2203662C2 (xx)
SE (1) SE9602442D0 (xx)
SK (1) SK284204B6 (xx)
TR (1) TR199802647T2 (xx)
UA (1) UA64715C2 (xx)
WO (1) WO1997048380A1 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
AU3967399A (en) * 1998-04-30 1999-11-16 Sepracor, Inc. S-rabeprazole compositions and methods
AU3870599A (en) * 1998-04-30 1999-11-16 Sepracor, Inc. R-rabeprazole compositions and methods
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
WO2000009498A1 (en) 1998-08-10 2000-02-24 Partnership Of Michael E. Garst, George Sachs And Jai Moo Shin Prodrugs of proton pump inhibitors
US7041313B1 (en) 1998-08-12 2006-05-09 Altana Pharma Ag Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
CA2161256C (en) * 1993-04-27 2004-06-29 Nancy M. Gray Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
PT723436E (pt) * 1994-07-08 2002-02-28 Astrazeneca Ab Forma de dosagem em comprimidos com unidades multiplas
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole

Also Published As

Publication number Publication date
IS4923A (is) 1998-12-15
CN1178648C (zh) 2004-12-08
IS2216B (is) 2007-03-15
HK1018590A1 (en) 1999-12-30
ATE252885T1 (de) 2003-11-15
YU56698A (sh) 2004-12-31
US20090036494A1 (en) 2009-02-05
NZ332990A (en) 2000-07-28
EE9800435A (et) 1999-06-15
DE69725860T2 (de) 2004-09-09
DK0921787T3 (da) 2004-02-23
DE69725860D1 (de) 2003-12-04
NO985964L (no) 1999-02-22
ES2208921T3 (es) 2004-06-16
PT921787E (pt) 2004-03-31
CZ420398A3 (cs) 2000-02-16
HUP9901794A2 (hu) 2000-04-28
EP0921787A1 (en) 1999-06-16
EE04606B1 (et) 2006-04-17
CZ298213B6 (cs) 2007-07-25
NO323295B1 (no) 2007-03-05
AU726859B2 (en) 2000-11-23
IL127542A (en) 2006-08-01
CA2257405A1 (en) 1997-12-24
TR199802647T2 (xx) 1999-03-22
US20010008900A1 (en) 2001-07-19
HUP9901794A3 (en) 2002-11-28
BR9709838A (pt) 1999-08-10
SE9602442D0 (sv) 1996-06-20
US20070276007A1 (en) 2007-11-29
SK165598A3 (en) 1999-08-06
EP0921787B1 (en) 2003-10-29
CN1222074A (zh) 1999-07-07
IL127542A0 (en) 1999-10-28
RS49590B (sr) 2007-06-04
RU2203662C2 (ru) 2003-05-10
JP2000512993A (ja) 2000-10-03
PL189716B1 (pl) 2005-09-30
NO985964D0 (no) 1998-12-18
AU3469097A (en) 1998-01-07
UA64715C2 (en) 2004-03-15
WO1997048380A1 (en) 1997-12-24
US20050113418A1 (en) 2005-05-26
PL330910A1 (en) 1999-06-07

Similar Documents

Publication Publication Date Title
SK284204B6 (sk) Použitie inhibítora H+, K+-ATPázy
US6605303B1 (en) Oral pharmaceutical extended release dosage form
US20030008903A1 (en) R-lansoprazole compositions and methods
US6403616B1 (en) Chemical process and pharmaceutical formulation
US20040171647A1 (en) S(-)rabeprazole compositions and methods
EA012261B1 (ru) Лекарственные формы, содержащие ингибитор протонного насоса и прокинетический агент
AU2004285394B2 (en) Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux
EP1353624B1 (en) Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
KR100483092B1 (ko) H+,k+-atp아제억제제의투여방법
JP2006506377A (ja) テナトプラゾール及びヒスタミンｈ２受容体拮抗剤を組み合わせた医薬組成物
TR201723047A2 (tr) Bir proton pompası inhibitörü ile prukaloprid içeren farmasötik bileşim.
TR201723199A2 (tr) Yeni farmasötik bileşimler.
ZA200103340B (en) Improved chemical process and pharmaceutical formulation.

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100618